skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Choroidal neovascularization in patient undergoing growth hormone treatment

Case report

(2440) Views  (509) Full article downloads

Authors: João R de Oliveira Dias, Eduardo B Rodrigues, Maurício Martinazzo, Michel E Farah

Published Date August 2008 Volume 2009:3 Pages 89 - 90
DOI: http://dx.doi.org/10.2147/OPTH.S3835

João R de Oliveira Dias1, Eduardo B Rodrigues2, Maurício Martinazzo2, Michel E Farah2

1Faculty of Medicine, University of Passo Fundo, Rio Grande do Sul, Brazil; 2Department of Ophthalmology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil

Abstract: The association between growth-hormone (GH) and neovascular retinopathies in nondiabetic patients has been reported in earlier series. We report occurrence of choroidal neovascularization (CNV) in a 15-year-old male patient undergoing long-term GH therapy. The CNV could be a consequence of the GH-intake in a susceptible myopic patient.

Keywords: choroidal neovascularization, growth hormone, optical coherence tomography, retina, angiogenesis








Readers of this article also read:

Nonarteritic anterior ischemic optic neuropathy associated with chronic anemia: a case series of myelodysplastic syndrome patients
Age-related macular degeneration: current treatments
Treatment of neovascular age-related macular degeneration: Current therapies
Central retinal artery occlusion following severe blow-out fracture in young adult
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy